11.28
-0.22
(-1.91%)
As of 3:55:34 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-50,158.00
-53,845.00
-25,074.00
-13,825.00
-12,029.00
Investing Cash Flow
5,261.00
-54,211.00
-3,548.00
-28.00
-19.00
Financing Cash Flow
51,788.00
129,672.00
1,714.00
55,194.00
4,859.00
End Cash Position
37,615.00
38,327.00
19,786.00
46,277.00
4,952.00
Capital Expenditure
-178.00
-48.00
-3,548.00
-28.00
-19.00
Issuance of Capital Stock
53,541.00
135,615.00
2,030.00
56,096.00
5,025.00
Repayment of Debt
-232.00
-158.00
-159.00
-98.00
-98.00
Free Cash Flow
-50,336.00
-53,893.00
-28,622.00
-13,853.00
-12,048.00
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ENGNW enGene Holdings Inc.
0.9500
+3.78%
CELUW Celularity Inc.
0.0699
+5.91%
ENGN enGene Holdings Inc.
6.77
-4.72%
SLN Silence Therapeutics plc
5.30
+0.95%
TSHA Taysha Gene Therapies, Inc.
1.5100
+2.03%
WVE Wave Life Sciences Ltd.
11.60
-3.86%
CELU Celularity Inc.
2.0999
-5.03%
GPCR Structure Therapeutics Inc.
30.05
-0.89%
BEAM Beam Therapeutics Inc.
25.95
-4.88%
CORT Corcept Therapeutics Incorporated
66.78
-4.46%